-
公开(公告)号:WO2021163610A1
公开(公告)日:2021-08-19
申请号:PCT/US2021/018019
申请日:2021-02-12
Applicant: SPIRAL THERAPEUTICS INC. , DE JUAN, Eugene , AYOOB, Andrew , ERICKSON, Signe , FARINAS, Kathleen
Inventor: DE JUAN, Eugene , AYOOB, Andrew , ERICKSON, Signe , FARINAS, Kathleen
Abstract: Active agents that bind to VEGF or a VEGF receptor and reduce the severity of a condition associated with BLB disruption and/or angiogenesis, for example anti-VEGF antibodies or tyrosine kinase inhibitor small molecules, can be locally, regionally or systemically administered to an individual with an otic disease or condition, such as Ménière's Disease, Autoimmune Inner Ear Disease, sensorineural hearing loss and noise-induced hearing loss, to alleviate symptoms of the disease or condition, for example, due to edema and endolymphatic dysfunction. An effective amount of these compounds can be delivered by intratympanic or intracochlear administration. Other methods of administration include, but are not limited to, topical, parenteral, subcutaneous, intraperitoneal and intranasal. Formulations may be, for example, for immediate release, sustained release, or controlled release.
-
公开(公告)号:WO2021150894A2
公开(公告)日:2021-07-29
申请号:PCT/US2021/014618
申请日:2021-01-22
Applicant: SPIRAL THERAPEUTICS INC.
Inventor: DE JUAN, Eugene , ERICKSON, Signe , LIMB, Charles , PERIS, Hugo , AYOOB, Andrew , LEVERING, Vrad
IPC: A61F11/00 , A61F2/18 , A61B1/018 , A61B1/227 , A61B17/29 , A61B17/320068 , A61B17/3205 , A61B17/3423 , A61B17/3468 , A61B17/3478 , A61B18/04 , A61B18/1485 , A61B18/20 , A61B2017/00115 , A61B2017/00323 , A61B2017/00331 , A61B2017/00787 , A61B2017/00867 , A61B2017/32007 , A61B2017/345 , A61B2018/00327 , A61B2217/005 , A61F11/002 , A61F11/004 , A61F2/958 , A61F2002/183 , A61F2250/0067 , A61M2037/0023 , A61M2037/0046 , A61M2205/04 , A61M2210/0662 , A61M2210/0668 , A61M31/00 , A61M31/002 , A61M37/0015 , G02B21/0012 , G02B21/0032 , G02B21/22
Abstract: Systems and methods can be employed for trans-tympanic membrane access to the middle ear for delivery of a therapeutic agent, for example, to the round window niche adjacent to the cochlea under direct visualization. The systems and methods can also be used to improve accessibility and visualization for various otological surgical procedures, such as, but not limited to, cholesteatoma removal, tympanic membrane repair and ossicular chain repair.
-
公开(公告)号:WO2020176419A1
公开(公告)日:2020-09-03
申请号:PCT/US2020/019517
申请日:2020-02-24
Applicant: SPIRAL THERAPEUTICS, INC.
Inventor: SACHERMAN, Kevin W. , AYOOB, Andrew , ERICKSON, Signe , PERIS, Hugo , LIMB, Charles , DE JUAN, Jr., Eugene
Abstract: A system for delivering one or more therapeutics to a region of the ear, the region being internal to a tympanic membrane. The system includes a canal guide configured to be inserted within and fittingly engaged with walls of the ear canal and needle assembly having a flexible shaft sized to extend through the canal guide. The canal guide provides alignment of the needle assembly within the ear canal relative to the tympanic membrane. The canal guide includes a viewing lumen extending between a proximal end to a distal-most end of the canal guide and is sized to remain external to the tympanic membrane. The canal guide includes a guide lumen extending to a distal opening near the distal-most end of the canal guide. The guide lumen curves from a first axis to a second axis. Related devices, systems, and methods are provided.
-
公开(公告)号:WO2019204653A1
公开(公告)日:2019-10-24
申请号:PCT/US2019/028189
申请日:2019-04-18
Applicant: SPIRAL THERAPEUTICS, INC.
Inventor: SACHERMAN, Kevin, W. , ERICKSON, Signe , PERIS, Hugo , DE JUAN, Jr., Eugene
IPC: A61F11/00
Abstract: An implantable device for delivering a therapeutic agent to treat an ear of a patient includes a body having a distal end region and a proximal end region. The body defines, at least in part, a reservoir configured to contain the therapeutic agent. The device includes a shaft attached to the distal end region of the body and a lumen extending through the shaft having at least one inlet at a proximal end region in fluid communication with the reservoir and at least one outlet at a distal end region. Upon implantation of the body in a region of the ear, a length of the shaft is sufficient to extend from the body to at least the round window membrane of the ear. The device is configured to deliver the therapeutic agent to the ear from the reservoir via passive diffusion. Related devices and methods are described.
-
公开(公告)号:WO2021150890A2
公开(公告)日:2021-07-29
申请号:PCT/US2021/014612
申请日:2021-01-22
Applicant: SPIRAL THERAPEUTICS INC.
Inventor: DE JUAN, Eugene , PERIS, Hugo , ERICKSON, Signe , LEVERING, Vrad
IPC: A61F11/00 , A61F2/18 , A61B1/018 , A61B1/227 , A61B17/29 , A61B17/320068 , A61B17/3205 , A61B17/3423 , A61B17/3468 , A61B17/3478 , A61B18/04 , A61B18/1485 , A61B18/20 , A61B2017/00115 , A61B2017/00323 , A61B2017/00331 , A61B2017/00787 , A61B2017/00867 , A61B2017/32007 , A61B2017/345 , A61B2018/00327 , A61B2217/005 , A61F11/002 , A61F11/004 , A61F2/958 , A61F2002/183 , A61F2250/0067 , A61M2037/0023 , A61M2037/0046 , A61M2205/04 , A61M2210/0662 , A61M2210/0668 , A61M31/00 , A61M31/002 , A61M37/0015 , G02B21/0012 , G02B21/0032 , G02B21/22
Abstract: Systems and methods can be employed for trans-tympanic membrane access to the middle ear for delivery of a formulation or implant device to a target location under direct visualization. The systems and methods can also be used to improve accessibility and visualization for various otological surgical procedures, such as, but not limited to, cholesteatoma removal, tympanic membrane repair and ossicular chain repair.
-
公开(公告)号:WO2021150887A1
公开(公告)日:2021-07-29
申请号:PCT/US2021/014609
申请日:2021-01-22
Applicant: SPIRAL THERAPEUTICS INC.
Inventor: DE JUAN, Eugene , ERICKSON, Signe , LEVERING, Vrad
IPC: A61F11/00 , A61B19/00 , A61B90/00 , G02B21/22 , G02B30/34 , A61B1/018 , A61B1/227 , A61B17/29 , A61B17/320068 , A61B17/3205 , A61B17/3423 , A61B17/3468 , A61B17/3478 , A61B18/04 , A61B18/1485 , A61B18/20 , A61B2017/00115 , A61B2017/00787 , A61B2017/00867 , A61B2017/32007 , A61B2018/00327 , A61B2217/005 , A61F11/002 , A61F11/004 , A61F2/958 , A61F2002/183 , A61F2250/0067 , A61M2037/0023 , A61M2037/0046 , A61M2205/04 , A61M2210/0662 , A61M2210/0668 , A61M31/00 , A61M31/002 , A61M37/0015 , G02B21/0012 , G02B21/0032
Abstract: Devices, systems, and methods can be employed to facilitate indirect viewing into cavities such as, but not limited to, the middle ear space. Some embodiments have uses such as, but not limited to, facilitating visualization and procedures in the outer, middle, and/or inner ear in order to diagnose and/or treat disorders including, but not limited to, hearing loss and other ear disorders. In particular implementations, a surgical microscope is used in conjunction with an inverter lens and a distal lens. In some cases, the distal lens transverses a membrane or septum such as, but not limited to, the tympanic membrane. The distal lens can be an assembly combining two or more lenses, in some embodiments. For example, in some cases wide angle lenses, zoom lenses, lenses of other various shapes and/or prisms can be used in the distal lens.
-
7.
公开(公告)号:WO2021150858A1
公开(公告)日:2021-07-29
申请号:PCT/US2021/014561
申请日:2021-01-22
Applicant: SPIRAL THERAPEUTICS INC.
Inventor: DE JUAN, Eugene , ERICKSON, Signe , LIMB, Charles , PERIS, Hugo , TALREJA, Nikhil , AYOOB, Andrew
IPC: A61F11/00 , A61B1/018 , A61B1/227 , A61B17/29 , A61B17/320068 , A61B17/3205 , A61B17/3423 , A61B17/3468 , A61B17/3478 , A61B18/04 , A61B18/1485 , A61B18/20 , A61B2017/00115 , A61B2017/00787 , A61B2017/00867 , A61B2017/32007 , A61B2018/00327 , A61B2217/005 , A61F11/002 , A61F11/004 , A61F2/958 , A61F2002/183 , A61F2250/0067 , A61M2037/0023 , A61M2037/0046 , A61M2205/04 , A61M2210/0662 , A61M2210/0668 , A61M31/00 , A61M31/002 , A61M37/0015 , G02B21/0012 , G02B21/0032 , G02B21/22
Abstract: Intra-tympanic injections of therapeutics into the inner ear can be used to treat conditions such as hearing loss. One or more stabilizing devices that define working channels can be temporarily implanted in the tympanic membrane. Purpose-built instruments such as endoscopes, forceps, and injections instruments can be passed through the working channels of the stabilizer devices to access the inner ear where the therapy can be administered. Afterwards, the stabilizing devices can be removed from the tympanic membrane and the tympanic membrane can heal, typically without the need for sutures.
-
公开(公告)号:WO2021231563A1
公开(公告)日:2021-11-18
申请号:PCT/US2021/031977
申请日:2021-05-12
Applicant: SPIRAL THERAPEUTICS INC. , DE JUAN, Eugene , ERICKSON, Signe , AYOOB, Andrew , FARINAS, Kathleen
Inventor: DE JUAN, Eugene , ERICKSON, Signe , AYOOB, Andrew , FARINAS, Kathleen
Abstract: Provided herein are polymer compositions and extended release otic agents. In one aspect, provided herein is a polymer composition including about 5% to about 15% by weight of the polymer composition of a functional polymer, wherein the functional polymer includes a first functional group, about 0.05% to about 0.6% by weight of the polymer composition of a crosslinker, wherein the crosslinker includes a second functional group, and water, wherein a crosslinking reaction can occur between the first functional group and the second functional group to form a gel, and wherein the polymer composition has a gelation time of about 45 seconds to about 60 minutes at a temperature of about 20 °C.
-
公开(公告)号:WO2021150888A1
公开(公告)日:2021-07-29
申请号:PCT/US2021/014610
申请日:2021-01-22
Applicant: SPIRAL THERAPEUTICS INC.
Inventor: DE JUAN, Eugene , PERIS, Hugo , ERICKSON, Signe , LEVERING, Vrad , TALREJA, Nikhil
IPC: A61F11/00 , A61B1/018 , A61B1/227 , A61B17/29 , A61B17/320068 , A61B17/3205 , A61B17/3423 , A61B17/3468 , A61B17/3478 , A61B18/04 , A61B18/1485 , A61B18/20 , A61B2017/00115 , A61B2017/00787 , A61B2017/00867 , A61B2017/32007 , A61B2018/00327 , A61B2217/005 , A61F11/002 , A61F11/004 , A61F2/958 , A61F2002/183 , A61F2250/0067 , A61M2037/0023 , A61M2037/0046 , A61M2205/04 , A61M2210/0662 , A61M2210/0668 , A61M31/00 , A61M31/002 , A61M37/0015 , G02B21/0012 , G02B21/0032 , G02B21/22
Abstract: Devices, systems, and methods can be employed to facilitate performing procedures in the outer, middle, and/or inner ear in order to diagnose and/or treat disorders including, but not limited to, hearing loss and other ear disorders. For example, this document describes devices, systems and methods that include instruments and techniques to minimize the invasiveness and/or to enhance the efficacy of procedures that are performed in the outer, middle, and/or inner ear spaces such as mastoidectomy, tympanoplasty, cholesteatoma treatments, otosclerosis treatments, and Eustachian tube treatments.
-
公开(公告)号:WO2021150881A1
公开(公告)日:2021-07-29
申请号:PCT/US2021/014601
申请日:2021-01-22
Applicant: SPIRAL THERAPEUTICS INC.
Inventor: DE JUAN, Eugene , ERICKSON, Signe , LIMB, Charles , LEVERING, Vrad
IPC: A61F11/00 , A61B1/018 , A61B1/227 , A61B17/29 , A61B17/320068 , A61B17/3205 , A61B17/3423 , A61B17/3468 , A61B17/3478 , A61B18/04 , A61B18/1485 , A61B18/20 , A61B2017/00115 , A61B2017/00787 , A61B2017/00867 , A61B2017/32007 , A61B2018/00327 , A61B2217/005 , A61F11/002 , A61F11/004 , A61F2/958 , A61F2002/183 , A61F2250/0067 , A61M2037/0023 , A61M2037/0046 , A61M2205/04 , A61M2210/0662 , A61M2210/0668 , A61M31/00 , A61M31/002 , A61M37/0015 , G02B21/0012 , G02B21/0032 , G02B21/22
Abstract: Systems and methods can be employed for facilitating access and procedures in the outer, middle, and inner ear in order to diagnose or treat ear disorders including, but not limited to hearing loss and excessive ear wax. In some examples, the systems and methods include instruments and techniques that facilitate trans-tympanic membrane or trans-fibrous ring access to the middle ear. The systems and methods can also be used to improve accessibility for various otological surgical procedures, such as, but not limited to, cholesteatoma removal, tympanic membrane repair and ossicular chain repair.
-
-
-
-
-
-
-
-
-